Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
21,913,894
-
Share change
-
-1,003,664
-
Total reported value
-
$101,905,916
-
Price per share
-
$4.64
-
Number of holders
-
54
-
Value change
-
-$5,571,403
-
Number of buys
-
27
-
Number of sells
-
30
Institutional Holders of FOAMIX PHARMACEUTICALS LTD - SHS (FOMX) as of Q2 2017
As of 30 Jun 2017,
FOAMIX PHARMACEUTICALS LTD - SHS (FOMX) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,913,894 shares.
The largest 10 holders included
GREAT POINT PARTNERS LLC, BAKER BROS. ADVISORS LP, FRANKLIN RESOURCES INC, DSC Advisors, L.P., Opaleye Management Inc., PERCEPTIVE ADVISORS LLC, AXA, Tekla Capital Management LLC, Vivo Capital, LLC, and DEERFIELD MANAGEMENT CO.
This page lists
54
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.